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Abstract
Stress granules (SGs) are membraneless cell compartments formed in response to different stress stimuli, wherein translation
factors, mRNAs, RNA-binding proteins (RBPs) and other proteins coalesce together. SGs assembly is crucial for cell survival,
since SGs are implicated in the regulation of translation, mRNA storage and stabilization and cell signalling, during stress.
One defining feature of SGs is their dynamism, as they are quickly assembled upon stress and then rapidly dispersed after
the stress source is no longer present. Recently, SGs dynamics, their components and their functions have begun to be
studied in the context of human diseases. Interestingly, the regulated protein self-assembly that mediates SG formation
contrasts with the pathological protein aggregation that is a feature of several neurodegenerative diseases. In particular,
aberrant protein coalescence is a key feature of polyglutamine (PolyQ) diseases, a group of nine disorders that are caused by
an abnormal expansion of PolyQ tract-bearing proteins, which increases the propensity of those proteins to aggregate.
Available data concerning the abnormal properties of the mutant PolyQ disease-causing proteins and their involvement in
stress response dysregulation strongly suggests an important role for SGs in the pathogenesis of PolyQ disorders. This
review aims at discussing the evidence supporting the existence of a link between SGs functionality and PolyQ disorders, by
focusing on the biology of SGs and on the way it can be altered in a PolyQ disease context.
Facts
● Stress granules (SGs) are non-membranous foci that
assemble as one of the first responses to cellular
stress, being composed by 40S ribosomal subunits,
translation initiation factors, poly(A)+ mRNAs and
RNA-binding proteins (RBPs).
● SGs functions include global translational arrest,
biomolecules storage, mRNA triage and expression
regulation, cell signalling and apoptosis, and viral
replication inhibition.
● RBPs are the main components of SGs and are
crucial for neuronal gene expression regulation,
which is highlighted by the fact that 50% of known
RBPs are expressed in the brain.
● SGs co-localize with the pathological protein
aggregates often associated with neurodegenerative
diseases, including amyotrophic lateral sclerosis,
frontotemporal lobar degeneration, and Alzheimer’s
disease.
● Polyglutamine diseases are neurodegenerative
disorders caused by proteins that bear an
abnormally expanded glutamine stretch and that
form insoluble aggregates.
Open questions
● Can any parallels be drawn between SGs assembly
and the multiprotein aggregation observed in
polyglutamine diseases?
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● Can SGs assembly dynamics be explored as a
therapeutic target in the context of polyglutamine
diseases?
● Does ataxin-2 or any other SG-composing RBP hold
a particular role in the pathophysiological network of
polyglutamine spinocerebellar ataxias that could
help explain the similarities existing between these
diseases?
● Is the involvement of SGs in polyglutamine diseases
cytotoxicity mechanisms related with the regionally
selective neurodegeneration profiles observed in
these disorders?
● How do SGs deal with the CAG-expanded mRNAs
that are generated in the context of polyglutamine
diseases, and that have been described to be toxic
even when untranslated?
Introduction
Cells are repeatedly exposed to different stress stimuli
during their lifetime. Stressing factors include conditions
such as heat, nutrient shortage or hypoxia, as well as the
dysfunction of particular cellular pathways or the accu-
mulation of reactive oxygen species. Since cell stress
affects homeostasis and normal cell functioning, stressing
factors need to be overcome in order to ensure cell sur-
vival. Accordingly, cells utilize a wide range of mechan-
isms to cope with stress, involving, for example,
transcriptional changes and alterations of protein degra-
dation pathways, and eventually culminating in apoptosis
in case they are unable to resist the aggressions.
One important set of mechanisms that cells use to
overcome stress entails alterations in intracellular orga-
nization, through the formation of specialized membra-
neless compartments1. Stress granules (SGs) are one type
of compartments whose assembly in the cytoplasm is
essential for the cellular response to stress. SGs are known
to contain a combination of ribosomal subunits, mRNA
molecules and functionally diverse proteins, especially
RNA-binding proteins (RBPs), but their exact functions
have not been completely elucidated. Available evidence
nonetheless indicates that SGs assembly constitutes an
advantage in the context of cellular stress: (i) in these
conditions, SG formation is more rapid than the tran-
scriptional or translation changes brought about by the
cellular stressors; (ii) important cellular molecules are
protected from degradation upon SGs assembly during
stress; and (iii) SGs disassembly after stress relief allows
cells to have proteins and mRNAs ready to be used2.
While SGs are essential for normal cell functioning
and to their adaptation to suboptimal environmental
conditions, there is growing evidence suggesting that a
persistent cellular stress state, in which SGs are also
persistent, may underlie an enhanced susceptibility to
aging or aging-related diseases, including
neurodegenerative disorders (NDs) and cancer3. Addi-
tionally, in different NDs characterized by abnormal
protein aggregation, not only are cells subjected to
diverse sources of stress, but several stress–response
pathways also seem to fail, possibly aggravating the
pathology4. The current literature review aims to pro-
vide an updated outline of SGs biology and to explore
and discuss the putative existence of a functional link
between SG formation, a regulated process of biomo-
lecule coalescence, and polyglutamine (PolyQ) diseases
pathogenesis, often attributed to a contrastingly aber-
rant phenomenon of multiprotein aggregation and
sequestration.
What are stress granules?
When cells are subjected to a stress stimulus, one of
their first responses is the formation of non-membranous
organelles called stress granules (SGs). These cellular foci
essentially consist of messenger ribonucleoprotein
(mRNPs) complexes, in which mRNAs are stalled and
translation inhibited, in order to save energy for the
remainder components of the cellular response to stress5.
SGs were first described in tomato cell lines exposed to
cellular stress induced by heat shock, and were thus
initially designated as heat-stress granules (HSG)6.
Through electron microscopy, the authors observed that
the granular aggregates that were formed were highly
enriched in heat shock protein 17 (Hsp17). Later, SG
formation was also described in chicken embryo fibro-
blasts, wherein concentrated heat shock protein 24
(Hsp24) was detected in distinct insoluble aggregates
found in the cytoplasm upon heat shock7. Since then,
several studies demonstrated that SGs are formed in dif-
ferent in vitro models of diverse organisms, including
plants, protozoans, fungi, Caenorhabditis elegans and
mammalians, as well as in animal tissues and human
patient samples.
SGs are mainly composed of stalled pre-initiation
translation complexes: 40S ribosomal subunits, transla-
tion initiation factors, poly(A)+ mRNAs and RBPs8.
Additionally, SG components also include protein kinases,
RNA helicases, structural constituents of ribosomes,
calcium-binding proteins, hydrolases and cytoskeletal
proteins (Fig. 1). This complex and diverse composition of
SGs suggests a notable variety of pathways and mechan-
isms in which these foci can be involved, and the crucial
roles SGs assembly/disassembly has in the context of
normal cellular function.
Importantly, SGs composition is different depending on
the cellular context, as well as on the type of stressing
factor causing their assembly, and its duration9. Taking
this into consideration, our group has analysed and
curated the available SG literature describing SG com-
ponents detected in mammalian cells. To the best of our
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knowledge, we annotated all the protein components
recruited to mammalian SGs that have been described so
far, gathering them in an online open-access database
(https://msgp.pt/)10. Currently, our database comprises
464 proteins identified as components of SGs, categoriz-
ing them according to their molecular functions or usual
subcellular localization, and providing information about
the type of cell or stressing condition in which they were
detected.
Stress granule formation and dynamics
A defining feature of SGs is their dynamism, as these
foci quickly assemble upon stress induction and rapidly
disperse when stressing conditions abate. The assembly
and composition of SGs depend on the type of cells in
question, the particular stressing factors involved and the
signalling pathways that are activated. SG formation can
be triggered by different conditions, such as endoplasmic
reticulum stress, oxidative stress, heat shock, hypoxia,
starvation, presence of translation-blocking drugs, viral
infection, knockdown of specific translation initiation
factors and overexpression of specific RBPs11.
In the canonical SGs assembly pathway (Fig. 2), the first
step is the phosphorylation of eukaryotic translation
initiation factor 2 subunit alpha (eIF2α)12 by one of the
four kinases: general control non-derepressible-2 (GCN2,
or eIF2α kinase 4 (EIF2AK4)); pancreatic eIF2α kinase
(PEK; alternatively PKR-like ER kinase (PERK) or eIF2α
kinase 3 (EIF2AK3)); protein kinase R (PKR) or haem-
regulated inhibitor (HRI); or eIF2α kinase 1 (EIF2AK1)13.
The structure of each of these kinases contains specific
regulatory regions that detect and recognize different
stress stimuli. Phosphorylation of eIF2α leads to transla-
tional arrest and dissociation of translation initiation
complexes from polysomes8. This results in the accu-
mulation of mRNAs, translation factors, RBPs and other
proteins that have intrinsically disordered domains (IDDs)
or prion-like domains (PLDs)14. These regions are low-
complexity sequences enriched in glycine and uncharged
polar amino acids (serine, asparagine and glutamine), and
often punctuated by aromatic (like tyrosine and pheny-
lalanine) or charged residues15,16. They promote numer-
ous electrostatic interactions between different regions of
a protein, and between different proteins, giving rise to
two regionally distinct states within the assembling
granules: a stable core, surrounded by a dynamic shell16.
Core components of SGs—including nucleating RBPs
such as ras GTPase-activating protein-binding protein 1
(G3BP1), T-cell intracellular antigen-1 (TIA-1), TIA-1-
related (TIAR) protein, tristetraprolin (TTP), and fragile
X mental retardation protein (FMRP)—bind to each
other, as well as to polyadenylated mRNAs and 40S
ribosomal subunits17, and induce the recruitment of other
proteins, initiating the process of aggregation in the
cytoplasm (Fig. 2). This event is denominated as primary
aggregation and results in the formation of the stable core.
Fig. 1 Stress granule components. Stress granules are multimolecular cytoplasmic foci that assemble as part of the cellular response to stress. They
largely derive from stalled pre-initiation translation complexes and are mainly comprised of poly(A)+ mRNA molecules, 40S ribosomal subunits and a
vast array of proteins (more than 450). The majority of these are RNA-binding proteins (RBPs) that bind to each other and to the other SG
components. They include eukaryotic translation initiation factor 2 subunit alpha (eIF2α), ras GTPase-activating protein-binding protein 1 (G3BP1),
T-cell intracellular antigen-1 (TIA-1), polyadenylate-binding protein 1 (PABP1), ataxin-2, fragile X mental retardation protein (FMRP) and tristetraprolin
(TTP). The unspecified shapes coloured in grayscale represent the remaining proteins counted among the numerous SG protein components
described so far.
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In the secondary aggregation event, SG nucleators induce
homotypic and heterotypic interactions between different
SG components, resulting in the maturation of SGs
and forming the shell, where numerous dynamic, and
weaker, protein interactions occur. Proteins recruited to
the foci include secondary RBPs such as heterogenous
Fig. 2 (See legend on next page.)
Marcelo et al. Cell Death and Disease          (2021) 12:592 Page 4 of 17
Official journal of the Cell Death Differentiation Association
nuclear ribonucleoprotein A0 (hnRNPA0), hnRNPA1,
hnRNPA2B1, RNA-binding protein EWS (EWSR1)18 and
ataxin-219. This mature state produces a liquid–liquid
phase separation, i.e. the weak, but numerous, inter-
molecular interactions established between the RBPs
generate a fluid droplet in the core of the aqueous cytosol,
constituting a non-membranous organelle18,20. This type
of phase separation of biomolecules, commonly involving
proteins containing IDDs, is currently regarded as a fun-
damental and ubiquitous aspect of subcellular compart-
mentalization, playing critical roles in many cellular
processes. In the case of SGs, the dynamic nature of the
phase separation allows the transition of several proteins
and RNA remodelling complexes between the core and
the shell of the SGs, and even between these foci and the
surrounding cytosol21.
A non-canonical pathway of SG assembly, independent
from eIF2α phosphorylation, has also been reported22. It
has been shown that inhibition of the eukaryotic initiation
factor 4F (eIF4F) complex prevents the formation of the
48S initiation complex, inhibiting ribosome activity and
arresting translation initiation. These events lead to SG
formation, independently from eIF2α phosphorylation22.
SGs rapid dissipation upon stress removal allows the
recycling of their components for immediate cellular use,
in a process that is regulated by molecular chaperons
(Fig. 2)1. In neurons, autophagy also seems to be impli-
cated in SGs disassembly23, although it may not be the
preferred pathway for their clearance24. SGs disassembly
correlates positively with a recovery in overall protein
synthesis and with the translation of several mRNAs25.
Stress granules functions
Classically, SGs have been understood to serve as cel-
lular storage foci responsible for translational arrest dur-
ing a stress event26,27. Currently, they are also admitted to
play a more active role in the stress response, participating
in mRNA triage, stress signalling and apoptosis induction,
among other processes. All of these functional roles are at
least partially interconnected, and largely derive from the
interplay between the individual functions of the diverse
proteins and mRNA species that gather and coalesce into
the SGs (Fig. 3).
Global translational arrest
The first role proposed for SGs was that of effectors of
stress-induced translational arrest28. During stress, and
upon phosphorylation of translation initiation factor
eIF2α, SGs are assembled and translation is arrested,
suggesting that these foci have functions connected with
mRNA translation and localization28. For example, during
cold shock-stress, global protein synthesis is suppressed
and SGs are assembled, both ensuring cell survival during
hypothermia29.
It has been hypothesized that transiently formed SGs
function as foci where RNA translation is repressed and
reprogramed under stressful conditions27. The fact that
small ribosomal subunits, translation initiation factors,
different signalling molecules and other players involved
in translation besides RBPs are also assembled into SGs2
strengthens the idea that SGs may be crucially active
effectors of translational repression. Moreover, it has also
been suggested that SGs may be integrated with miRNA-
induced translational silencing pathways30.
Additionally, SG formation is positively correlated with
a decrease in global translation levels2 and several SG
components are known to function as translational reg-
ulators. For example, a study has shown that the ablation
of ataxin-2 leads to a reduction in the global translation
rate31. The assembly of proteins (mainly RBPs) and
mRNAs in SGs may prevent these components from
integrating the translational machinery, thus contributing
to the repression effect2,27.
It is not completely clear if SGs assembly per se is
important for the translational repression of certain
mRNAs and further studies are needed to clearly establish
SGs definitive role in these mechanisms. In fact, some
studies have suggested that SG formation is not essential
for global translation repression during stress32 and that
the impairment of SGs assembly by depletion of core
factors does not affect global protein synthesis33.
(see figure on previous page)
Fig. 2 The canonical stress granule assembly pathway. (1) Formation of stress granules (SGs) can be triggered by diverse cell damaging
conditions, including viral infection, oxidative stress, heat shock, nutrient deprivation, ultraviolet radiation or proteotoxic stress. Particular stress
conditions are detected by specific kinases—protein kinase R (PKR), haem-regulated inhibitor (HRI), general control non-derepressible-2 (GCN2) and
pancreatic eIF2α kinase (PEF)—that then become activated and (2) phosphorylate eukaryotic translation initiation factor 2 subunit alpha (eIF2α). (3)
eIF2α is involved in the formation of translation initiation complexes and, when phosphorylated, leads to dissociation of these complexes and to
translational arrest. (4) mRNAs, 40S ribosomal subunits, and proteins involved in translation start to accumulate and to assemble together, along with
other proteins that are recruited to the forming SGs. This primary aggregation process produces a stable SG core. RNA-binding proteins (RBPs) that
constitute SG cores include ras GTPase-activating protein-binding protein 1 (G3BP1), T-cell intracellular antigen-1 (TIA-1), tristetraprolin (TTP) and
fragile X mental retardation protein (FMRP). (5) A secondary aggregation step resulting from additional, albeit weaker, intermolecular interactions
originate the shell of the SGs. RBPs recruited in this step include heterogenous nuclear ribonucleoprotein A0 (hnRNPA0), hnRNPA1, hnRNPA2B1 and
RNA-binding protein EWS (EWSR1). (6) When stress conditions abate, SGs are either disassembled by molecular chaperons or (7) are cleared by
autophagy. (8) Disassembly allows for a rapid recovery of protein synthesis.
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Biomolecules storage
In line with the SGs proposed role in translational arrest
is also their function of storage. Since de novo protein
synthesis is an energetically expensive process for the cell,
SGs constitute transient storage sites for mRNAs released
from disassembled polysomes during stress. This confers
an advantage to the cells that form SGs, from an energetic
point of view. While SGs are forming, many mRNAs, such
Fig. 3 (See legend on next page.)
Marcelo et al. Cell Death and Disease          (2021) 12:592 Page 6 of 17
Official journal of the Cell Death Differentiation Association
as those corresponding to housekeeping genes, are selec-
ted to be stored in these foci2,34. When the stressful period
ceases, SGs are disassembled and the stored mRNAs can
either move back to polysomes to restart translation, or be
degraded in processing bodies34,35.
mRNA triage and expression regulation
SGs have consequently been implicated in the mRNA
triage process34,35, through which mRNA molecules from
disassembling polysomes are sorted and the fate of indi-
vidual transcripts is determined. Supporting this hypoth-
esis, evidence has shown that, during arsenite-induced
stress36, mammalian SGs dock with processing bodies
(PBs), which constitute another type of cytoplasmic foci
that has been implicated in mRNA storage and, especially,
decay. While docking, SGs and PBs share many protein
components, including Fas-activated serine/threonine
kinase (FASTK), 5ʹ−3ʹ exoribonuclease 1 (XRN1), eukar-
yotic translation initiation factor 4E (eIF4E), TTP and
butyrate response factors 1 and 2 (BRF1and BRF2)36, as
well as several mRNA species37. In the presence of envir-
onmental cellular stress, both PBs and SGs are simulta-
neously assembled and, through the exchange of
components, SGs may prioritize the translation or degra-
dation of some mRNA transcripts over others, thereby
altering the proteome until stress conditions subside.
Whereas specific transcripts are selected for decay by
destabilizing proteins (e.g. TTP), other transcripts are
bound by stabilizing proteins (e.g. Hu-antigen R (HuR),
otherwise known as ELAV-like protein1, ELAVL1) for
transport or storage, within the SGs or elsewhere27. SGs
assembly may help cells prevent the accumulation of
misfolded proteins by reducing the synthesis of certain
transcripts, while optimizing the translation of mRNAs
involved in stress response. For example, several mRNAs
encoding proteins involved in stress response, like heat
shock proteins, are excluded from SGs36.
It has also been proposed that SGs may promote
destabilization of mRNAs by conditioning the activity of
several stabilizing proteins, like HuR or zipcode-binding
protein-1 (ZBP1), therein contained25,32. The recruitment
of these proteins to SGs limits their cytoplasm availability,
and thus their function. For example, it was shown that
ZBP1 knockdown induced a selective destabilization of its
target mRNAs38.
Some studies have challenged this view of SG’s role in
mRNA triage, suggesting that SGs are not required for
mRNAs destabilization during stress39,40. For example,
one study showed that the stabilization of bulk mRNA
including ZBP1 target transcripts is largely independent of
SG formation during a stress stimulus40.
Cell signalling and apoptosis
In cells undergoing stress there is an interplay between
diverse signalling pathways and SG formation. SG forma-
tion communicates a “state of emergency” through the
interception of subsets of signalling molecules, which in
turn triggers a cascade of signalling events that regulate SGs
assembly. The localized enrichment of proteins in SGs may
either serve to increase the rate of biochemical reactions
within these foci or to reduce the cytosolic concentration of
specific proteins by sequestration, both resulting in the
alteration of several cell signalling pathways41.
By modulating several signalling pathways during stress,
SGs interfere with cell survival, metabolism and growth.
In particular, SGs assembly and dynamics may be
important in the cellular decision to undergo apoptosis or
not, depending on the response to stress. Several apop-
tosis regulatory factors are recruited to SGs, possibly
inhibiting or delaying stress-induced cell death signal-
ling41. For example, during severe, apoptosis-inducing,
stress, the receptor of activated protein C kinase 1
(RACK1) protein binds to stress-responsive MAP 3 kinase
(MTK1) and facilitates its activation; during modest stress
RACK1 is recruited to SGs, limiting MTK1 kinase acti-
vation and avoiding apoptosis42. The recruitment of
regulatory-associated protein of mTOR (Raptor) to SGs
also prevents the overactivation of mTORC1 signalling,
thus inhibiting apoptosis43. Additionally, in stressed cells,
SG formation reduces the production of reactive oxygen
(see figure on previous page)
Fig. 3 Stress granules functions. Stress granules (SGs) participate in the cellular response to stress through a set of different actions that are
interconnected and derive from the individual activities of SG components and from the assembly/disassembly of these foci. A SG formation involves
the disassembly of translation initiation complexes and the coalescence of mRNAs molecules, ribosomal subunits and many proteins involved in
translation, resulting in translational arrest and protein synthesis suppression. Additionally, several SG components are known to act as translational
repressors. B SGs function as stores of RNAs and proteins in cells under stress, but allow rapid mobilization of these molecules when the damaging
conditions subside. C SGs may modulate the expression of specific proteins during stress, by directing particular mRNA species to different possible
fates. This action appears to involve an exchange of mRNAs between SGs and processing bodies, upon docking of these two types of RNA granules.
Translation of some proteins involved in stress responses may be prioritized, some mRNAs may be kept stored in SGs or elsewhere, while others, such
as those codifying proteins prone to misfolding, may be targeted for degradation by the processing bodies. D By intercepting particular signalling
molecules, SGs may trigger signalling cascades that regulate or modify cell growth, survival or metabolism, or which promote apoptosis. E SGs play a
role in the cellular response against viral infection, by sequestering the endogenous translational machinery necessary for viral protein expression and
by activating proteins involved in antiviral response.
Marcelo et al. Cell Death and Disease          (2021) 12:592 Page 7 of 17
Official journal of the Cell Death Differentiation Association
species, thereby also preventing apoptosis44. Also in line
with SGs participation in cell survival decisions, other
studies reported that impairing SGs assembly leads to a
decrease in cell viability after stress exposure45, and that
inhibiting SG formation by oxidizing TIA-1 made cells
more vulnerable to apoptosis46.
The role that SGs have in cellular growth appears to
involve regulation of the mTOR pathway, which monitors
nutrient levels and energy availability to promote either
cell growth, when conditions are favourable, or catabolic
processes, during stress29,43,47. For example, the dual
specificity tyrosine-phosphorylation-regulated kinase 3
(DYRK3), which is recruited to SGs, phosphorylates the
mTORC1 inhibitor proline-rich AKT1 substrate 1
(PRAS40), allowing mTORC1 to exit SGs in an activated
state and to fulfil its signalling functions in cell growth
and metabolism47.
Viral replication inhibition
SGs can impact virus replication and force viral
adaptation by sequestering and binding cell components
as part of their role in translational arrest and RNA
decay. For example, TIA-1, TIAR (ref. 48), G3BP1
(ref. 49), translation initiation factors and the 40S ribo-
some subunit—all of them components of SGs—are
required for the replication of any virus. Additionally,
SGs that are induced during viral infection recruit many
innate immune proteins, and several studies have
revealed that SGs serve as a platform for activation of
protein kinase R (PKR) and the retinoic acid-inducible
gene I (RIG-I) dsRNA helicase, which are both essential
to initiate antiviral response50,51. Thus, SGs can have
inhibitory effects on viral replication, acting as players in
the antiviral response52. Conversely, several reviews
describe that different virus interfere with SG formation
and regulation, consequently affecting the cellular
functions of these granules52.
RNA-binding proteins, stress granules and human
disease
So far, more than 1000 mammalian genes have been
identified as coding for RBPs, and 20% of all known
proteins are RBPs53. In line with this, and as mentioned
above, RBPs are one of the main components of SGs: from
the 464 proteins identified as SG components10, 252
(54%) are classified as RBPs54. RBPs have low-complexity
domains, that make them prone to aggregation and
facilitate protein-protein interactions, possibly explaining
their high prevalence in SGs18.
RBPs are involved in different steps of RNA metabolism
and thus control many aspects of an RNA molecule life
cycle in the cell. These functions of RBPs vary according
to their subcellular localization. For example, in the
nucleus, RBPs have been implicated in functions such as
the regulation of mRNA maturation, RNA polymerase
elongation and nuclear export55. In the cytoplasm, RBPs
seem to be involved in the regulation of RNA transport,
silencing, translation and degradation56. The wide range
of functions performed by RBPs are mainly due to the
multiplicity of their interaction domains, which allow
them to interact with many different proteins57.
Being essential for a wide variety of cell functions,
ranging from the regulation of gene expression to post-
transcriptional processes, it is not surprising that dysre-
gulation in the expression of different RBPs has been
suggested to underlie several human disorders, including
cancer and NDs58,59. Similarly, perturbations in the
assembly or localization of SGs, which are supported by
RPBs, may be involved in different human conditions
including cancer60, aging11 and NDs8.
For example, it was found that at least 30 different RBPs
were upregulated in different types of cancers. The authors
of this study proposed the idea that fluctuating RBP levels
could result in the increase of non-specific protein inter-
actions with an important impact on the disease out-
come61. In human breast cancer biopsies, cancer cells
sometimes accumulate the metastatic lymph node gene 51
(MLN51) RBP, in discrete cytoplasmic foci resembling
SGs45, which is in line with studies that have associated SG
formation to the resistance to chemotherapeutic drugs62.
It has also been found that the expression of several
RBPs is reduced in aged individuals, suggesting that they
could play important roles in maintaining tissue home-
ostasis with advancing age63.
RBPs, stress granules and neurodegeneration
More than 50% of known RBPs are expressed in the
brain, where they are involved in different processes such
as alternative splicing, transport, localization, stabilization
and translation of RNAs64. Importantly, RBPs are com-
ponents of neuronal RNA granules, also called transport
ribonucleoprotein particles (RNPs), which are motile
structures that transport mRNA and contain several
translational components65.
Given the important role of RBPs for cellular function, it
is expected that their dysregulation may have a profound
effect in neuronal health, contributing to the disruption of
different pathways underlying the pathogenesis of NDs. In
fact, several studies have shown that different SG-
nucleating RBPs are associated with neuronal defects.
For example, it has been shown that depletion of SG core
component G3BP1 in neurons leads to an increase in
intracellular calcium and calcium release. This implicates
G3BP1 in the control of neuronal plasticity and calcium
homeostasis, establishing a link between SG formation
and neuronal dysfunction66.
The possible link between NDs and SGs is strongly
supported by evidence of co-localization between these
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foci and the pathological protein aggregates often asso-
ciated with degenerative diseases of the nervous system.
Different SG components are present in the pathological
protein aggregates of conditions that include amyotrophic
lateral sclerosis (ALS), frontotemporal lobar degeneration
(FTLD) or Alzheimer’s disease (AD)67. The possible
implication of SGs in the context of NDs has been
explored in recent years, especially in the case of AD and
ALS (refs. 18,68). It was shown that SGs assembly in
neuronal cells promotes the formation of phosphorylated
tau inclusions and, likewise, tau seems to stimulate SG
formation69. Another study found that the chronic
exposure to the amyloid-beta peptide stimulates the for-
mation of persistent SGs, which are also found in patients
with severe AD (ref. 70). Moreover, in AD, several SG
components accumulate in affected cells and co-localize
with pathogenic tau69,71. In ALS, SG components such as
TIA-1, eukaryotic translation initiation factor (eIF3) or
polyadenylate-binding protein (PABP) co-localize with
neuropathology markers in patients’ brain72. The accu-
mulation of TAR DNA-binding protein 43 (TDP-43)
inclusions was shown to be associated with SGs, the two
co-localizing in degenerating neurons72. In fact, different
studies showed that prolonged SG formation may con-
tribute directly to ALS (ref. 73).
The possible role of SGs in the pathogenesis of NDs is
also highlighted by the fact that mutations or malfunc-
tions in the genes encoding for different SG components
are the direct cause of some of these disorders or are
closely implicated in pathogenesis, in other cases. For
example, abnormal expansions in FMRP cause fragile X
mental retardation syndrome (FXS), mutations in Sur-
vival motor neuron 1 (SMN1) are linked to spinal mus-
cular atrophy (SMA), while mutations in TDP-43, FUS,
optineurin (OPTN), and angiogenin (ANG) cause motor
neuron diseases, including ALS (ref. 18). Mutated TDP-
43, the major pathological protein in sporadic ALS, is
associated with the inactivation of 5ʹAMP-activated
protein kinase (AMPK), which is induced by energy
depletion and metabolic stress, thus impacting the out-
come of ALS (ref. 74). Recently, Sleigh and colleagues
also reported that mice expressing mutated TDP-43
exhibited a deficit in axonal transport of signalling
endosomes, contributing decisively to the neuropathol-
ogy observed in the disease75. Mutant expansion in the
CAG tract of ataxin-2 causes spinocerebellar ataxia type
2 (SCA2), and intermediate size expansions in the same
protein are a risk factor for ALS (ref. 76). A loss-of-
function mutation of LIN28A in patient-derived human
embryonic stem cells / induced pluripotent stem cells
and in a mouse model contributes to Parkinson’s disease
(PD) pathology77.
Altogether, there is important evidence suggesting a
major role for SGs in the pathogenesis of NDs.
RBPs, stress granules and polyglutamine disorders
Polyglutamine (PolyQ) disorders constitute a group of
hereditary NDs, which includes Huntington’s disease
(HD), spinal and bulbar muscular atrophy (SBMA),
dentatorubral-pallidoluysian atrophy (DRPLA) and six
types of spinocerebellar ataxia (SCAs). These disorders
are caused by an abnormal expansion of CAG triplets in
the open reading frame of the causative genes, which
encode for an expanded PolyQ tract in the respective
proteins. The different PolyQ-causing proteins are
otherwise unrelated and display no significant similarity
besides the PolyQ tract; it is this common feature—the
PolyQ tract—that, when expanded, affects their local and
global protein structure and promotes abnormal self-
assembly78. PolyQ protein aggregation culminates in the
formation of multiprotein, macromolecular, intracellular
inclusions, which are a key histological feature of PolyQ
disorders.
The toxic nature of the molecular species that are
formed during the aggregation process is still a matter of
debate, and it remains unclear whether aggregation is the
cause, or the consequence of the progressive neurode-
generation observed in PolyQ disorders. It has been sug-
gested that the formation of expanded PolyQ-containing
aggregates in the nucleus and/or the cytoplasm occurs
before other cell defects are detected79. In fact, expanded
PolyQ-containing proteins are known to have a tendency
to spontaneously self-assemble, even in vitro, forming
insoluble aggregates80. On the other hand, some authors
have suggested that aggregates, and especially the macro-
molecular inclusions observed in post-mortem patients’
brains, may represent an end-stage manifestation, poster-
ior to the toxicity events leading to neurodegeneration81.
Current evidence it still insufficient to draw a clear
picture of the events linking expanded PolyQ protein
expression and disease, but, despite all the uncertainties,
the tendency of expanded PolyQ-containing proteins to
engage in aberrant interactions and aggregate have been
repeatedly pointed as factors responsible for cell toxicity
in the context of PolyQ disease pathogenesis. Aggregation
disturbs protein-folding homeostasis and alters the solu-
bility and localization of other proteins82,83. PolyQ protein
aggregates display a tendency to sequester functionally
diverse proteins and thereby disrupt the cell systems with
which they are engaged84. In particular, this phenomenon
may compromise transcription, protein quality control
and intracellular transport, as a result of the documented
sequestration of transcription factors, chaperons, protea-
some components and motor proteins85–87. As an
example, it was shown that expansion of the PolyQ seg-
ment of huntingtin (Htt) beyond the pathological
threshold for HD resulted in the structural perturbation
of an adjacent (fused) β-barrel protein, increasing the
propensity of both to aggregate88.
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The pathological protein aggregation process occurring
in PolyQ disorders starkly contrasts with the regulated
and functional protein coalescence observed in SGs
assembly. However, RBPs may be especially susceptible to
the multiprotein aggregation cascades triggered by
expanded PolyQ, given the fact that they contain low-
complexity domains and have some propensity to aggre-
gate per se80,89,90. Moreover, mutations in several SG
components are known to increase their propensity to
aggregate and to induce SG formation8.
It is thus logical to envision that the increased tendency
of PolyQ proteins to aggregate and abnormally interact
with other proteins may promote the recruitment of SGs,
or at least some of their components, into pathological
protein agglomerates. This may affect the normal func-
tions of those components, and compromise SGs action
in countering cell stress. Additionally, protein sequestra-
tion, along with a multifactorial and permanent state of
cell stress caused by PolyQ-expanded protein expression,
may alter SGs dynamic assembly and disassembly process,
again compromising their biological roles. The abnormal
SGs that are formed as part of a chronic stress response
may themselves constitute a source of further cell toxicity.
The following sections discuss the hypothesis whereby
SGs dysfunctionality, caused by these diverse, albeit
related, events, plays a pivotal role in the pathogenesis of
PolyQ disorders.
Sequestration of stress granules components into PolyQ
aggregates
It has been demonstrated that proteins with very long
intrinsically disordered domains (IDDs), which are fre-
quent in RBPs, are particularly vulnerable to be recruited
into PolyQ aggregates91. In particular, Ratovitski and
colleagues92 have shown that expanded huntingtin pre-
ferentially interacts with proteins containing IDDs.
Aggregates formed by PolyQ-containing proteins have
been described to be β-rich fibrillar structures of amyloid
nature, which induce cytotoxicity by sequestering com-
ponents of quality control systems and transcriptional
machinery; this type of aggregates has been shown to
interact with functionally diverse RBPs87,90,93,94.
In fact, studies show that SG components are usually
found in the neuropathological protein aggregates that are
characteristic of PolyQ diseases76,95,96. For example, it was
demonstrated that TIA-1 co-localizes with perinuclear
mutant Htt aggregates, in cell cultures97, and with the Htt
mutant aggregates of a HD mouse model95. In SCA2
patients, TDP-43 co-localizes with pathological inclusions
of mutant ataxin-2, itself a SG component76.
In transfected cells, aggregates of an Htt fragment in the
cytoplasm caused the sequestration and mis-localization of
proteins containing disordered and low-complexity
sequences, significantly impacting their nucleo-cytoplasmic
transport94. Concordantly, mRNA abnormalities were
detected in HD transgenic mice: a fraction of analysed
neurons presented either mRNA nuclear accumulation or
an overall reduction of mRNA levels.
Cell stress in PolyQ diseases
While the molecular and cellular physiopathology of
PolyQ diseases still poses many unanswered questions, it
is increasingly clear that it involves the dysfunctionality of
several cell systems. Accordingly, current evidence sug-
gests that cells affected by PolyQ toxicity are subjected to
cell stress from more than one source. In particular, it has
been reported that PolyQ-expanded protein expression
triggers proteotoxic and oxidative stress98,99.
Correct folding of proteins and maintenance of their
structural integrity is essential for cell homeostasis.
PolyQ-expanded proteins pose challenges to the
mechanisms responsible for proteostasis, as they are
prone to aggregate and to engage in abnormal inter-
molecular interactions. Proteotoxic stress is associated
with a collapse of the protein quality control mechanisms,
namely those involving the activity of molecular chaper-
ones and protein-degradation systems98,100. These
mechanisms have been described to be impacted by
PolyQ protein expression: for example, chaperones and/or
proteasome components have been detected in protein
aggregates associated with HD, SCA1, SCA3 and SBMA,
in cell models101–103, animal models104,105 and patient
brain samples106,107; autophagy has been described to be
impaired in animal models of SCA1 and SBMA
(refs.108,109), and in patients of HD, SCA3, SCA7
(refs. 110,111,112). Endoplasmic reticulum stress, translated
as an accumulation of proteins of the secretory pathway in
this cell compartment, may also constitute a facet of
proteotoxic stress in PolyQ diseases113. It has been sug-
gested to be a consequence of the endoplasmic reticulum-
associated degradation impairment that has been
observed to arise upon expression of expanded PolyQ
proteins114. For example, in SCA3, it was shown that
changes in the interaction between ataxin-3 and valosin-
containing protein (VCP/p97) leads to dysfunctions in
ataxin-3 function as a regulator of endoplasmic
reticulum-associated degradation115. Imbalances in the
misfolded protein load in the endoplasmic reticulum may
constitute a source of proteotoxic stress.
One of the targets of PolyQ protein toxicity is mito-
chondrial function99,116,117. In experimental models of
several PolyQ diseases, including HD, SCA3 and SCA2,
changes in these mitochondria have been associated with
the disruption of the redox equilibrium and the produc-
tion of reactive oxygen species, the effectors of oxidative
damage to biomolecules118,119. Importantly, levels of
oxidative stress markers have been described to be
increased in HD patients’ brain120 and in blood samples
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from HD (ref. 121) and SCA3 patients122. For example, in
fibroblasts of SCA2 patients, it was found that expanded
ataxin-2 interacts with NADPH oxidase membrane sub-
unit gp91, activating its enzymatic activity123. This trig-
gers a signalling cascade that appears to be responsible for
the generation of an oxidative wave that induces mito-
chondrial stress, DNA damage, and inhibition of neural-
specific transcription.
These and other sources of cell stress may contribute to
a state of chronic stress in cells affected by PolyQ protein
toxicity. Adding to the direct injuring impact that the
stressors have on affected cells, PolyQ protein toxicity may
render some stress response systems dysfunctional and
lead to a state of increased vulnerability to stress124. Sur-
mounting evidence does suggest that stress response is
aberrantly altered in the context of PolyQ diseases.
Molecular chaperone heat shock protein 70 (Hsp70) was
shown to be downregulated in a HD mouse model, and
this effect was suggested to result from transcription factor
NF-Y sequestration by mutant Htt125. Ataxin-3 has been
shown to activate transcription factor forkhead box pro-
tein O4 (FOXO4) and induce the expression of manganese
superoxide dismutase (SOD2), an antioxidant enzyme,
under oxidative stress conditions; however, when ataxin-3
is expanded, this transcriptional activation effect is
reduced and, in fact, SOD2 levels are decreased in SCA3
patients brain samples126. Levels of several antioxidant
molecules, including cysteine, glutathione and ascorbic
acid have been described to be lowered in HD (ref. 116).
Expression of cystathionine γ-lyase, an enzyme involved in
cysteine biosynthesis, was shown to be decreased in HD
patient brain samples127. The team that produced these
observations further suggested that this effect resulted
from mutant Htt inhibitory effect on specificity protein 1,
a transcriptional activator of cystathionine γ-lyase.
Altered stress granule assembly and disassembly
A chronic state of cell stress may interfere with the
normal functionality of the stress response mechanisms,
including SGs. This abnormal activation of stress responses
may, in turn, have a deleterious effect on cell survival. As
mentioned, pathological aggregation of PolyQ proteins and
the abnormal interactions in which they engage can result
in significant changes in the protein clearance mechanisms
and in the cellular stress response pathways124,128, possibly
preventing formed SGs from disassembling and/or hin-
dering SG assembly in response to stress.
The biological features of both the core and the shell of
SGs can be altered during a stress response, and thus vary
according to the duration of the stress stimulus. In an
acute, transient, stress state, induced by conditions such
as oxidative, metabolic, hypoxic, or thermal stress, SGs
appear in the cytoplasm of the cells. Chronic SGs are
fundamentally different from the ones assembled during
acute stress conditions. Although only a limited number
of reports regarding the composition of chronic SGs is
available, this type of granules appears to act as a nidus for
the aggregation of some disease-linked proteins. During
persistent periods of stress, the phase-separated proteins
of the shell can mature to become a gel-like layer, pro-
moting aggregation, and turning into more stable com-
plexes18. For example, it was reported that chronic SGs
can recruit the ubiquitin-binding protein p62 and induce
post-translational modification of RBPs by phosphate
groups or ubiquitin129.
Interestingly, the prolonged coalescence of RBPs pro-
motes the accumulation of β-sheet structured proteins,
which can stack to form large macromolecular com-
plexes16,130. Aggregated, β-rich fibrillar structures of
amyloid nature have been repeatedly associated with
diverse human conditions; not only PolyQ diseases, as
mentioned above, but also with other NDs as well,
including AD and PD. Stable amyloid aggregates con-
taining proteins and RNA are suggested to play a central
role in NDs, provoking the disruption of post-
transcriptional changes131. Like Htt, a fragment of TDP-
43, a SG component that forms detectable aggregates in
ALS and frontotemporal dementia patients, was also
described to cause protein mis-localization and RNA
accumulation in the nucleus94. Cytotoxic amyloid aggre-
gation in PolyQ diseases may thus result not only from
PolyQ protein self-assembly, but also by the persistence of
SGs induced by a chronic stress state.
One possible cause for imbalance of SG formation in
PolyQ diseases concerns the autophagy pathway. It has
been shown that enhanced autophagy activity reduces the
number of SGs132. It was also shown that SGs are cleared
by autophagy in mammalian cells, as their clearance is
reduced by the inhibition of autophagy or by the depletion
of VCP/p97, which is implicated in the pathway5. Later, it
was shown that SGs are cleared by autophagy through the
promotion of the formation of autophagosomes due to
the recruitment of Syk kinase, another protein involved in
autophagy, to SGs133. Autophagy has been demonstrated
to be impaired in PolyQ diseases and in other
NDs112,134,135. Thus, autophagy dysregulation may lead to
the persistence of SGs, and the consequent sequestering
of components thatate important in the cellular response
to stress. In turn, this process may contribute to the
consolidation of the pathological protein aggregates, since
it was shown that normal SGs are free of misfolded pro-
teins and autophagy players, whereas aberrant SGs con-
tain misfolded proteins, which attract autophagy
machinery components to SGs24,136.
Ataxin-2 as a hub for PolyQ toxicity
Taken together, the evidence presented suggests the
existence of a link between SGs dysfunctionality and the
Marcelo et al. Cell Death and Disease          (2021) 12:592 Page 11 of 17
Official journal of the Cell Death Differentiation Association
pathogenesis of PolyQ disorders, resulting from protein
aggregation and sequestration. One protein in particular
seems primed to play a central role in this toxic interplay
of aggregation-prone proteins. Ataxin-2, the protein that
causes SCA2 when its PolyQ tract is expanded beyond the
critical threshold of 32 glutamine residues, is itself a
component of SGs. Although its precise biological func-
tion is still unclear19, ataxin-2 is an RBP involved in SGs
assembly, and its depletion strongly reduces the number
of SG-positive cells upon stress induction137.
Ataxin-2 is present in the pathological protein aggre-
gates of at least one other PolyQ disorder, SCA3 (ref. 96).
What is more, we have shown that mutant protein
aggregation in SCA3 is associated with a significant
decrease in ataxin-2 mRNA and protein levels, as the
reestablishment of ataxin-2 levels mitigates the neuro-
pathological and behaviour deficits in different MJD/
SCA3 mouse models83. Impairment of ataxin-2 functions
in SCA2 and the other PolyQ diseases may produce an
imbalance in SG dynamics and interfere with other cell
systems with which ataxin-2 is involved; ataxin-2 interacts
directly with mRNAs138 and with several proteins, either
directly or indirectly139,140. In the case of SCA2, mutant
ataxin-2 is able to alter mRNA stability, namely by an
increase in transcripts levels, observed for STAU1, con-
tributing to aberrant protein aggregation141. Other study
reported that decreasing the expression of ataxin-2
reduced the aggregation of other RBPs, such as TDP-43,
increasing cellular survival and attenuating the patholo-
gical process in TDP-43 transgenic mice142.
One of the puzzling features of PolyQ diseases is the
fact that, although the genes and proteins that cause
them are unrelated, when abnormally expanded all of
them give rise to disorders affecting neuronal function
and survival. This is particularly striking in the case of
PolyQ SCAs, given the fact that they all involve a com-
promise of cerebellar structure and function and lead to
partially overlapping clinical signs143. It has been sug-
gested that genes and proteins involved in PolyQ SCAs
and other hereditary ataxias may be functionally related,
constituting the nodes of an intricate interaction net-
work144. This network may be especially crucial for
cerebellar cell function and survival and that would be
why, when one of its members is disrupted, the whole
network malfunctions, triggering common pathogenic
mechanisms that lead to cerebellar ataxia. In line with
this idea, for many years it has been known that many
genes that are responsible for PolyQ diseases are them-
selves modifiers of other PolyQ proteins toxicity145. For
example, in human SCA2 patients, alleles of SCA3 gene
ATXN3 with longer CAG tracts predict an earlier age of
onset146. If SG dysfunction is indeed a critical factor in
PolyQ disease pathogenesis, it is tempting to propose
that ataxin-2 may constitute an important nexus where
the network of ataxia-related genes and proteins
articulates with SGs machinery.
Final considerations
Ever since SGs were first described, several studies have
focused on investigating their assembly/disassembly
dynamics, their cellular functions, the components
recruited to these foci upon stress, and, more recently,
their possible involvement in human disease. Considering
that SGs are structures that result from a multiprotein
assembly process, it seems relevant to look for the relation
that SG formation may have with the aberrant protein
aggregation observed in several human disorders such as
PolyQ diseases, and the putative involvement of SGs in
this process. SGs rapidly assemble upon stress, and when
the stress stimulus is removed, they rapidly disappear. In
contrast, in PolyQ disorders protein aggregation is a
pathological and irreversible phenomenon.
SGs are mainly composed by RBPs, which are proteins
that frequently contain low-complexity domains. These
domains make RBPs more prone to aggregate, to interact
with other proteins and to be recruited to aggregates.
Inside cells, aggregate-prone RBPs normally participate in
the repeating and highly dynamic cycles of functional
assembly and disassembly of protein-RNA granules such
as SGs131. On the other hand, the pathological expansion
in PolyQ disorder-causing proteins causes them to
aggregate abnormally and stably. Their presence may
disrupt the normal RBP aggregation equilibrium; RBPs
from SGs and abnormal PolyQ-containing proteins may
produce an overactive aggregation phenomenon within
neurons, which could underlie and decisively contribute
to PolyQ disease pathogenesis. Sequestration of RBPs and
other components of stress response systems may con-
tribute to the transcriptional aberrations and the dys-
functions of other cell systems which are commonly
envisioned as effectors of cytotoxicity in PolyQ diseases99.
Cell stress, and stress response dysfunction, may further
exacerbate abnormal protein coalescence, further feeding
the aggregation cascade (Fig. 4).
PolyQ expansion and aggregation, possibly combined
with cell stress, may not only decrease the ability of cells
to eliminate the pathogenic protein but may also interfere
with SG dynamics. SG’s disassembly in neurons seems to
be linked to the autophagy pathway, which is dysregulated
in several NDs, including PolyQ disorders. Autophagy
impairment may contribute to the persistence of SGs,
conditioning the availability of translational factors,
mRNAs and other agents that are important for cellular
function and that constitute SGs.
Current perspectives on the biology of proteins bearing
low-complexity sequences suggest a putative mechanistic
link between SGs biophysical properties and the pathologic
aggregation of PolyQ-expanded proteins. Proteins enriched
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in low-complexity sequences are prone to form intracel-
lular liquid-like condensates, of which SGs are an exam-
ple20. Phase-separated membraneless organelles appear to
be metastable, and while they can disassemble, they can
also evolve into a solid-like state or they can directly drive
formation of amyloid-like fibrils, as has been demonstrated
for condensates of RBPs with low-complexity sequences
that act as SG components16. PolyQ-containing protein
aggregation has been long envisioned to be a nucleation-
dependent process, whereby a critical monomeric expan-
ded protein nucleus is initially formed, and other mono-
mers are subsequently added to it down an energy
gradient89,147. It has been proposed that the phase-sepa-
rated, protein-rich, environment of the SGs may provide
favourable conditions for amyloid-like fibrillization by
increasing the probability of nucleation and the rate of
monomer addition16. Physiological protein interactions
between SG components and PolyQ-containing proteins
may draw the latter to that environment, and in case they
bear an aggregation-inducing PolyQ expansion, this may
increase their tendency for pathogenic aggregation16.
Consistent with this, liquid-like condensates of expanded
Htt exon 1 have been shown to convert into fibrillar
structures, in vitro and in cells148. While the process
whereby liquid-like condensates may drive aggregation
nucleation is not known, this environment seems to be also
favourable for aggregate cross-seeding, i.e. for a particular
protein to drive the aggregation of other proteins149.
Functional coalescence of SG components and a possibly
physiological fibrillization process20 may thus trigger
pathogenic PolyQ protein cross- and self-assembly.
Importantly, cross-seeding between different PolyQ-
containing proteins or between a PolyQ protein and
other amyloid-forming proteins (including prion amyloids)
has been described150.
The idea that SGs play a relevant role in PolyQ diseases
pathogenesis opens up a new avenue of research and
interest in the field of PolyQ disorders, further linking it
Fig. 4 The putative involvement of stress granules in the molecular pathophysiology of polyglutamine diseases. Proteins bearing an
expanded polyglutamine (PolyQ) tract display a tendency to aggregate and to engage in aberrant intermolecular interactions. Association of PolyQ-
expanded proteins with stress granules (SGs) components, in particular RNA-binding proteins (RBPs) that are often prone to aggregate, may alter the
dynamics of SGs assembly and disassembly. This can compromise SGs functionality, contributing to the globally deficient cell stress response that has
been described to be a component of the molecular pathophysiology of PolyQ diseases. Oxidative stress (associated with an increase in reactive
oxidative species - ROS - levels) and proteotoxic stress, which are known to result from expanded PolyQ protein expression, may culminate in a state
of chronic cell stress, which may add to the abnormal SG assembly/disassembly dynamics and lead to the persistence of SGs. SGs formed under
chronic stress are known to acquire abnormal properties and to seed toxic aggregation. Defects in autophagy caused by PolyQ protein expression
may also contribute to the persistence of SGs and to their altered dynamics. Additionally, both the sequestration of RBPs to PolyQ aggregates and the
toxic aggregation triggered by SGs may alter RNA metabolism and its subcellular localization, which in turn may lead to transcriptional aberrations.
Chronic stress, a reduced ability to cope with cell stress, transcriptional alterations and a pernicious cascade of protein aggregation involving both the
PolyQ-expanded proteins and the SGs may combine to produce the cytotoxic profile with is at the basis of cell dysfunction and loss, in PolyQ
diseases.
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with the cellular mechanisms implicated in stress
response. Future studies will contribute to a better
understanding of the role of SGs in PolyQ disease
pathogenesis, eventually leading to the identification of
new molecular targets and to the development of new
therapeutic strategies. The study of SGs functional
aggregation may also constitute an interesting framework
for the study of pathogenic protein aggregation, which
plays a pivotal part not only in PolyQ diseases but also in
many other human degenerative conditions.
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